FDA Warning Letter to Trangs Group USA Incorporated for FSVP Violations
Summary
FDA issued a Warning Letter to Trangs Group USA Incorporated for failing to develop, maintain, and follow a Foreign Supplier Verification Program (FSVP) as required by section 805 of the FD&C Act and 21 CFR part 1, subpart L. An inspection conducted January 13–26, 2026 at the company's Garden Grove, California facility found that no FSVP existed for any imported foods, including Frozen Bao Mini Mushroom Teriyaki Bun from two foreign suppliers. The company must respond in writing within fifteen (15) working days with documentation of corrective actions or face refusal of admission and detention without physical examination (DWPE) of imported foods.
“You did not develop, maintain, and follow an FSVP, as required by section 805 of the FD&C Act and 21 CFR 1.502(a).”
Food importers subject to FSVP requirements should audit their programs to confirm each imported product has a corresponding FSVP that addresses the specific hazards and supplier controls for that product — certificates and HACCP plans for other products will not satisfy the requirement. Companies with frozen food imports from international suppliers should review DWPE exposure if their FSVP documentation is incomplete.
About this source
FDA Warning Letters are public notifications to firms the agency believes are significantly violating FDA regulations. Common triggers include Current Good Manufacturing Practice violations, unauthorized drug claims, substandard clinical trial conduct, unapproved marketing, and tobacco sales to minors. Letters require a written response within 15 working days. Around 75 letters land each month across drug manufacturers, medical device makers, tobacco retailers, and dietary supplement companies. Watch this if you run a regulated manufacturing operation, advise on FDA compliance, defend companies in enforcement matters, or track quality-system failures that precede recall events. GovPing publishes each letter with the recipient, agency division, and cited violations.
What changed
The FDA's inspection of Trangs Group USA Incorporated identified that the company failed to develop any Foreign Supplier Verification Program for foods it imports into the United States, in violation of 21 CFR 1.502(a). The company's prior responses, which included HACCP plans, BRCGS certificates, and IFS certificates, did not demonstrate how they apply to the specific Frozen Bao Mini Mushroom Teriyaki Bun products covered during the inspection. The FDA is requiring a corrective response within 15 working days.
Food importers subject to the FSVP regulation must develop and maintain a program that verifies foreign suppliers meet U.S. food safety standards. Companies that have not established an FSVP for their imported products face warning letters, refusal of admission under section 801(a)(3) of the FD&C Act, and placement on Detention Without Physical Examination (DWPE) under Import Alert # 99-41. Importers should review their supplier verification programs to ensure they address each specific imported food product.
What to do next
- Respond in writing within fifteen (15) working days from receipt of this letter
- Include documentation of changes made (e.g., copy of FSVP, records to demonstrate implementation)
- If unable to complete corrections within 15 working days, explain the reason for the delay and state when remaining violations will be corrected
Archived snapshot
Mar 18, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Delivery Method: Via Express Delivery Product: Food & Beverages Recipient: Recipient Name David NMI Ho Recipient Title CEO Trangs Group USA Incorporated 12881 Knott St Ste 219
Garden Grove, CA 92841-3942
United States
davidho@trangs.onmicrosoft.com Issuing Office: Office of Inspections and Investigations United States
02/24/2026
WARNING LETTER
Re: CMS # 723838
Dear Mr. Ho:
From January 13, 2026, through January 26, 2026, the Food and Drug Administration (FDA) conducted a Foreign Supplier Verification Program (FSVP) inspection of Trangs Group USA Incorporated located at 12881 Knott St Ste 219, Garden Grove, CA 92841-3942. This inspection was conducted to determine compliance with the requirements of section 805 of the Federal Food, Drug, and Cosmetic Act (FD&C Act) (21 U.S.C. 384a) and the implementing FSVP regulation in 21 CFR part 1, subpart L.
The FSVP regulation requires that importers perform certain risk-based activities to verify that human and/or animal food they import into the United States has been produced in a manner that meets applicable United States food safety standards. You may find information relating to the FSVP regulation and your responsibilities to comply with the regulation through links in FDA’s FSVP web page at https://www.fda.gov/food/food-safety-modernization-act-fsma/fsma-final-rule-foreign-supplierverification-programs-fsvp-importers-food-humans-and-animals.
During the inspection, we found that you are not in compliance with the requirements of 21 CFR part 1, subpart L for the foods you import. Because of these significant violations, you are not in compliance with section 805 of the FD&C Act. At the conclusion of the inspection, our investigator provided you with a Form FDA 483a FSVP Observations.
We acknowledge receipt of your responses, dated February 2, 2026, and February 5, 2026, in which you stated that you have responded to all necessary requirements to be FSVP compliant and that no other action is required by you. You also provided the following documents: Trangs Group USA FSVP SOP, Trangs Group USA Corrective Action Procedure, BRCGS Food Safety Certificate for (b)(4), IFS Certificate for (b)(4) HACCP plan for Frozen Steamed/Fried Bao Bun with Mixture Prawn and Vegetable Filling, BRCGS Food Safety Certificate for (b)(4), IFS Certificate for (b)(4), (b)(4) HACCP Plan for Frozen Steamed/Fried Bao Bun with Vegetables Filling, and additional HACCP plans for frozen shrimp-based products that are exempt from FSVP requirements. However, the documents provided do not indicate how they are relevant to the Frozen Bao Mini Mushroom Teriyaki Bun covered during the inspection, and you did not explain how they would apply to your FSVP program. Thus, these documents do not constitute an FSVP as required by section 805 of the FD&C Act and 21 CFR 1.502(a).
Your significant violations of the FSVP regulation are as follows:
You did not develop, maintain, and follow an FSVP, as required by section 805 of the FD&C Act and 21 CFR 1.502(a). Specifically, you did not develop an FSVP for any of the foods you import, including the following foods:
- Frozen Bao Mini Mushroom Teriyaki Bun, imported from (b)(4), located in (b)(4).
- Frozen Bao Mini Mushroom Teriyaki Bun, imported from (b)(4), located in (b)(4). The above violations are not intended to be an all-inclusive list of violations of the FSVP requirements. It is your responsibility to ensure that you are in compliance with section 805 of the FD&C Act and the implementing regulation in 21 CFR part 1, subpart L.
This letter notifies you of our concerns and provides you an opportunity to address them. If you do not adequately address this matter, we may take further action. For instance, we may take action under section 801(a)(3) of the FD&C Act (21 U.S.C. 381(a)(3)) to refuse admission of the food you import for which you appear to be in violation of section 805. We may place the foods you import into the United States on detention without physical examination (DWPE) when you import the foods. You can find DWPE information relating to FSVP in Import Alert # 99-41 at http://www.accessdata.fda.gov/cms_ia/ialist.html. In addition, the importation or offering for importation into the United States of an article of food without the importer having an FSVP that meets the requirements of section 805 of the FD&C Act or the FSVP regulation is prohibited under section 301(zz) of the FD&C Act (21 U.S.C. 331(zz)).
You should respond in writing within fifteen (15) working days from your receipt of this letter. Your response should address the specific things you are doing to correct any violations. You should include in your response documentation and information that would assist us in evaluating your corrections (e.g., documentation of changes you made, such as a copy of your FSVP, records to demonstrate implementation of your FSVP), and any additional information that you wish to supply relevant to your compliance with the FSVP regulation. If you believe that you are not in violation of the FD&C Act, include your reasoning and any supporting information for our consideration. If you cannot complete all corrections within 15 working days, you should explain the reason for your delay and state when you will correct any remaining violations.
Please send your reply to Food and Drug Administration, Attention: Celena Ngo, Compliance Officer, Division of West Coast Imports, One World Trade Center, Suite 300, Long Beach, CA 90831. If you have any questions regarding this letter, you may contact Celena Ngo via email at celena.ngo@fda.hhs.gov. Please reference CMS # 723838 on any documents or records you provide to us and on the subject line of any email correspondence you send to us.
Sincerely,
/S/
Dr. Kathleen Turner
Program Division Director
Division of West Coast Imports
- ## Content current as of:
03/17/2026
Regulated Product(s)
- Food & Beverages
CFR references
Named provisions
Mentioned entities
Citations
Parties
Related changes
Get daily alerts for FDA Warning Letters
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from FDA.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when FDA Warning Letters publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.